← Back to homepage
AstraZeneca sees stock market value slump by more than £20bn after drug setback
Sources
2
Coverage
Limited spectrum
Sentiment
-0.65
◀ Left 100%Centre 0%Right 0% ▶
How we rate bias →This story is currently only covered by 2 sources from a limited part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.
NewsDeck Poll
Do you think this story is being covered fairly across the political spectrum?
Loading…
Left
(2)
Independent Business
AstraZeneca sees stock market value slump by more than £20bn after drug setback
The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease.
9 Jul, 10:30
Evening Standard
AstraZeneca sees stock market value slump by more than £20bn after drug setback
The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease.
9 Jul, 10:30
Centre
(0)
No coverage from this perspective yet
Right
(0)
No coverage from this perspective yet